phosphatidylcholine O-42:6

An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 42 carbons and 6 double bonds.


phosphatidylcholine 44:4

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 44 carbons in total with 4 double bonds.


sphingomyelin 38:2

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 38 with 2 double bonds.


An N-hydroxyhexadecenoylsphingosine-1-phosphocholine in which the N-acyl group is specified as (9Z)-3-hydroxyhexadec-9-enoyl.


lysophosphatidylcholine (18:1/0:0)

A lysophosphatidylcholine 18:1 in which the acyl group is located at position 1.


sphingomyelin 46:1

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 46 with 1 double bond.


sphingomyelin 44:3

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 44 with 3 double bonds.


A 1-(Z)-alk-1-enyl-2-acyl-sn-glycero-3-phosphocholine in which the alk-1-enyl and acyl groups are specified as (1Z)-hexadecenyl and (9Z)-hexadecenoyl respectively.


lysophosphatidylcholine 16:3

A lysophosphatidylcholine in which the remaining acyl group (position unspecified) contains 16 carbons and 3 double bonds.


A  1-O-acyl-sn-glycero-3-phosphocholine in which the  1-acyl group is (10Z)-heptadecenoyl.


A phosphatidylcholine 42:1 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (15Z)-tetracosenoyl respectively.


phosphatidylcholine 44:6

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 44 carbons in total with 6 double bonds.


A phosphatidylcholine 34:2 in which the 1- and 2-acyl groups are specified as (2Z)-hexadecenoyl and (9Z)-octadecenoyl respectively.


sphingomyelin 12:0

A sphingomyelin in which the total number of carbons contained in the sphingoid base and fatty acyl groups is 12 with zero double bonds.


A glycerophosphocholine that consists of L-alpha-glycerophosphocholine carrying an unspecified alkyl substituent at position 1.


A 1-palmitoyl-2-acyl-sn-glycero-3-phosphocholine in which the 2-acyl group is specified as (11Z,14Z,17Z)-icosatrienoyl.


An N-acyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine in which the acyl group has 24 carbons and 0 double bonds.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 27 carbons and 0 double bonds.


A phosphatidylcholine 38:0 in which the acyl groups specified at positions 1 and 2 are hexadecanoyl and docosanoyl respectively.


A phosphatidylcholine 36:2 in which the acyl group both at positions 1 and 2 is octadecenoyl with double bond at unspecified position.


A phosphatidylcholine having a linoleoyl at sn-1 and a fatty acyl chain of unknown composition at sn-2. Major species at pH 7.3.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 18 carbons and 2 double bonds.


glycerophosphocholine

The glycerol phosphate ester of a phosphocholine. A nutrient with many different roles in human health.


A phosphatidylcholine 32:1 in which one acyl group has 16 carbons and is fully saturated while the other has 16 carbons and 1 double bond (position not specified).


A phosphatidylcholine 38:1 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (11Z)-eicosenoyl respectively.


sphingomyelin 41:1

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 41 with 1 double bond.


lysophosphatidylcholine (0:0/18:3)

A lysophosphatidylcholine 18:3 in which the acyl group is located at position 2.


A 2-acyl-sn-glycero-3-phosphocholine in which the 2-acyl group contains 18 carbons and is fully saturated.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 19 carbons and 0 double bonds and is 2-hydroxylated.


phosphatidylcholine 35:5

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 35 carbons in total with 5 double bonds.


phosphatidylcholine O-32:0

An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 32 carbons and 0 double bond.


A phosphatidylcholine 40:5 in which the acyl groups specified at positions 1 and 2 are (9Z)-octadecenoyl and (7Z,10Z,13Z,16Z)-docosatetraenoyl respectively.


A phosphatidylcholine 34:4 in which teh acyl groups specified at positions 1 and 2 are tetradecanoyl and (5Z,8Z,11Z,14Z)-eicosatetraenoyl respectively.


A sphingomyelin d18:1 in which the N-acyl group is specified as tetradecanoyl (myristoyl).


A phosphatidylcholine 42:10 in which one acyl group has 20 carbons and 4 double bonds while the other has 22 carbons and 6 double bonds (position not specified).


lysophosphatidylcholine 20:4

An acyl-sn-glycero-3-phosphocholine in which the remaining acyl group (position not specified) contains 20 carbons with 4 double bonds.


thioetheramide PC

A member of the class of 1-thio-sn-glycero-3-phosphocholines that is (2S)-2-amino-3-sulfanylpropyl 2-(trimethylazaniumyl)ethyl phosphate in which the amino group is substituted by a palmitoyl group and the thiol is substituted by a palmityl group. It is a reversible inhibitor of secretory phospholipase A2.


A phosphatidylcholine 36:1 in which the phosphatidyl acyl groups at positions 1 and 2 are stearoyl and oleoyl respectively.


An N-acyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine in which the acyl group has 22 carbons and 0 double bonds and is 2-hydroxylated.


sphingomyelin 40:0

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 40 with 0 double bonds.


A phosphatidylcholine 42:0 in which the acyl groups specified at positions 1 and 2 are tetracosanoyl and octadecanoyl respectively.


A 1-O-(alk-1-enyl)-sn-glycero-3-phosphocholine in which the alkenyl group has Z geochemistry.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 20 carbons and 0 double bonds.


lysophosphatidylcholine (18:2/0:0)

A lysophosphatidylcholine 18:2 in which the acyl group is located at position 1.


phosphatidylcholine 28:0

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 28 carbons in total with 0 double bonds.


A phosphatidylcholine 36:3 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (6Z,9Z,12Z)-octadecatrienoyl respectively.


A 2-acyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl and the acyl groups at positions 1 and 2 are specified as hexadecyl and docosahexaenoyl respectively.


A  phosphatidylcholine 33:1 in which the acyl groups specified at positions 1 and 2 are palmitoyl and (9Z)-heptadecenoyl respectively.


A 1-(Z)-alk-1-enyl-2-acyl-sn-glycero-3-phosphocholine in which the alk-1-enyl and acyl groups are specified as (1Z)-hexadecenyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


lysophosphatidylcholine 19:0

A lysophosphatidylcholine in which the acyl group has a fully saturated C19 chain and is attached to the glycero moiety at either position 1 or 2.


A phosphatidylcholine 34:2 in which one acyl group has 16 carbons and 1 double bond while the other has 18 carbons and 1 double bond (position not specified).


sphingomyelin 28:1

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 28 with 1 double bond.


trospium

A carboxylic ester resulting from the formal condensation of the carboxy group of hydroxy(diphenyl)acetic acid with the hydroxy group of (1S,3R,5R)-3-hydroxy-8lambda(5)-azaspiro[bicyclo[3.2.1]octane-8,1'-pyrrolidin]-8-ylium. Its chloride salt is used to treat overactive bladder.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups specified at positions 1 and 2 are palmitoyl and (11Z,14Z)-eicosadienoyl respectively.


lysophosphatidylcholine (P-16:0/0:0)

A 1-O-(alk-1-enyl)-sn-glycero-3-phosphocholine in which the alk-1-enyl group contains 16 carbons and no additional double bonds.


A phosphatidylcholine 32:3 in which the acyl groups at positions 1 and 2 are tetradecanoyl and (9Z,12Z,15Z)-octadecatrienoyl respectively.


sphingomyelin 28:4

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 28 with 4 double bonds.


An ammonium betaine formed by deprotonation of the phosphoric acid group of 6-(O-phosphocholine)hydroxyhexanoic acid.


A sphingomyelin in which the sphingoid component is specified as hexadecasphingosine.


phosphatidylcholine P-34:1

A 1-O-(alk-1-enyl)-2-O-acyl-sn-glycero-3-phosphocholine in which the alk-1-enyl and acyl groups contain a total of 34 carbon atoms with 1 additional double bond.


lysophosphatidylcholine 15:2

A lysophosphatidylcholine in which the remaining acyl group (position unspecified) contains 15 carbons and 2 double bonds.


A phosphatidylcholine O-42:4 in which the alkyl and acyl group specified at positions 1 and 2 are icosyl and (7Z,10Z,13Z,16Z)-docosatetraenoyl respectively.


sphingomyelin 28:3

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 28 with 3 double bonds.


An acyl-sn-glycero-3-phosphocholine in which the acyl group (with no specified position) is alpha-linolenoyl. Formula:C26H48NO7P.


phosphatidylcholine 30:0

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 30 carbons in total with 0 double bonds.


A 1-acyl-sn-glycero-3-phosphocholine in which the 1-acyl group contains 18 carbons and is fully saturated.


A phosphatidylcholine 38:5 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl respectively.


lysophosphatidylcholine O-18:0

A monoalkyl-sn-glycero-3-phosphocholine in which the alkyl group contains 18 carbons and no double bonds.


A sphingomyelin 38:1 obtained by formal condensation of the carboxy group of henicosanoic acid with the amino group of 14-methylhexadecasphingosine-1-phosphocholine. It is a metabolite of the nematode Caenorhabditis elegans.


phosphatidylcholine O-36:6

A glycerophosphocholine that is an alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 36 carbons and 6 double bonds.


A phosphatidylcholine 38:2 which carries an icosanoyl group at position 1 and a (6Z,9Z)-18-oxooctadeca-6,9-dien-18-yl group at position 2.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 16 carbons and 0 double bonds.


phosphatidylcholine 38:0

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 38 carbons in total with 0 double bonds.


monothioglycerophosphocholine

A monothioglycerol phosphate ester of a phosphocholine.


A glycerophosphocholine that is sn-glycero-3-phosphocholine bearing a single alk-1-enyl substituent at an unspecified position.


lysophosphatidylcholine 18:1

A lysophosphatidylcholine in which the remaining acyl group (position not specified) contains 18 carbons with 1 double bond.


A phosphatidylcholine 40:1 in which the acyl groups specified at positions 1 and 2 are (9Z)-octadecenoyl and docosanoyl respectively.


A phosphatidylcholine 34:1 in which the two acyl substituents at positions 1 and 2 are specified as oleoyl and palmitoyl respectively.


phosphatidylcholine 29:1

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 28 carbons in total with 1 double bond.


A 2-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as 5-oxovaleroyl.


A sphingomyelin in which the sphingoid component is specified as C17-sphinganine.


sphingomyelin 41:2

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 41 with 2 double bonds.


ammonium ion derivative

A derivative of ammonium, NH4(+), in which one (or more) of the hydrogens bonded to the nitrogen have been replaced with univalent organyl groups. The substituting carbon of the organyl group must not itself be directly attached to a heteroatom (thereby excluding protonated amides, hemiaminals, etc).


A phosphatidylcholine O-36:2 in which the alkyl and acyl groups specified at positions 1 and 2 are hexadecyl and (11Z,14Z)-eicosadienoyl respectively.


A phosphatidylcholine 36:2 in which the acyl groups specified at positions 1 and 2 are (9Z,12Z)-octadecadienoyl and octadecanoyl respectively.


phosphatidylcholine 38:7

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 38 carbons in total with 7 double bonds.


phosphatidylcholine 31:1

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 31 carbons in total with 1 double bond.


ELAIDYLPHOSPHOCHOLINE

A phosphocholine that is the mono-1-elaidyl ester of phosphocholine


A phosphatidylcholine 42:4 in which the acyl groups specified at positions 1 and 2 are (6Z,9Z,12Z)-octadecatrienoyl and (15Z)-tetracosenoyl respectively.


phosphatidylcholine P-36:4

A 1-O-(alk-1-enyl)-2-O-acyl-sn-glycero-3-phosphocholine in which the alk-1-enyl and acyl groups at positions 1 and 2 contain 36 carbon atoms in total with 4 additional double bonds.


A phosphatidylcholine 34:3 in which the acyl groups specified at positions 1 and 2 are palmitoyl and (9Z,12Z,15Z)-octadecatrienoyl (alpha-linolenoyl) respectively.


phosphatidylcholine O-45:1

A glycerophosphocholine that is an alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 45 carbons and 1 double bond.


lysophosphatidylcholine 18:2

A lysophosphatidylcholine in which the acyl group (position not specified) contains 18 carbons and 2 double bonds.


A N-octadecenolsphingosine-1-phosphocholine in which the acyl group specified is 9Z-octadecenoyl.


A phosphatidylcholine O-36:3 in which the alkyl and acyl groups specified at positions 1 and 2 are hexadecyl and (8Z,11Z,14Z)-eicosatrienoyl respectively.


phosphatidylcholine O-36:5

A glycerophosphocholine that is an alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 36 carbons and 5 double bonds.


A phosphatidylcholine 32:1 in which the acyl groups at C-1 and C-2 are tetradecanoyl and (9Z)-octadecenoyl respectively.


phosphatidylcholine 22:4

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 22 carbons in total with 4 double bonds.


phosphatidylcholine 40:2

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 40 carbons in total with 2 double bonds.


A 1-(Z)-alk-1-enyl-2-acyl-sn-glycero-3-phosphocholine in which the alk-1-enyl and acyl groups are specified as (1Z)-hexadecenyl and tetradecanoyl respectively.


A 1-O-alkyl-2-O-arachidonoyl-sn-glycero-3-phosphocholine where the alkyl group is specified as hexadecyl.


phosphatidylcholine O-44:3

A glycerophosphocholine that is an alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 44 carbons and 3 double bonds.


phosphatidylcholine 30:1

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 30 carbons in total with 1 double bond.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl substituents at positions 1 and 2 are specified as palmitoyl and butanoyl respectively.


A phosphatidylcholine 40:7 in which the acyl groups at C-1 and C-2 are (11Z)-octadecenoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A phosphatidylcholine 40:2 in which the acyl group specified at positions 1 and 2 is (11Z)-eicosenoyl respectively.


A phosphatidylcholine 38:6 in which the acyl groups specified at positions 1 and 2 are (9Z)-octadecenoyl and (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl respectively.


A phosphatidylcholine 38:4 in which the acyl groups at positions 1 and 2 are specified as oleoyl and (8Z,11Z,14Z)-icosatrienoyl respectively.


An N-acyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine in which the acyl group has 27 carbons and 0 double bonds.


A sphingomyelin in which the sphingoid component is specified as tetradecasphingosine.


sphingosylphosphorylcholine

A phosphosphingolipid consisting of sphingosine having a phosphocholine moiety attached to its primary hydroxyl group.


An N-acyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine in which the acyl group has 24 carbons and 0 double bonds and is 2-hydroxylated.


sphingomyelin 45:1

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 45 with 1 double bond.


A phosphatidylcholine 42:1 in which the acyl groups specified at positions 1 and 2 are docosanoyl and (11Z)-eicosenoyl respectively.


lysophosphatidylcholine 6:0

A lysophosphatidylcholine in which the remaining acyl group is specified as hexanoyl (caproyl). If R1 is the acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is the acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.


A lysophosphatidylcholine 16:0 in which the acyl group is specified as palmitoyl (hexadecanoyl) and is located at position 2.


A sphingomyelin d18:1 in which the N-acyl group is specified as (13Z)-docosenoyl.


A sphingomyelin in which the total number of carbons in the fatty acyl group is 26 with 1 double bond.


A phosphatidylcholine 38:6 in which the acyl groups at C-1 and C-2 are specified as palmitoyl and (4E,7E,10E,13E,16E,19E)-docosahexaenoyl respectively.


phosphatidylcholine O-40:1

An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 40 carbons and 1 double bond.


A phosphatidylcholine 36:3 in which the acyl group specified at positions 1 and 2 are hexadecanoyl and (8Z,11Z,14Z)-eicosatrienoyl respectively.


A sphingomyelin 33:1 obtained by formal condensation of the carboxy group of heptadecanoic acid with the amino group of hexadecasphingosine-1-phosphocholine.


phosphatidylcholine 36:0

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 36 carbons in total and 0 double bonds.


An N-hexadecanoyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine in which the acyl group has 16 carbons and 0 double bonds.


phosphatidylcholine 32:0

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 32 carbons in total with 0 double bonds.


A 2-acyl-1-alkyl-sn-glycero-3-phosphocholine in which the acyl and alkyl groups are specified as hexadecanoyl (palmitoyl) and hexadecyl respectively.


phosphatidylcholine 25:0

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 25 carbons in total with no double bonds.


phosphatidylcholine 48:2

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 48 carbons in total with 2 double bonds.


A  phosphatidylcholine 38:1 in which the acyl groups specified at positions 1 and 2 are eicosanoyl and (11Z)-octadecenoyl respectively.


An N-acylhexadecasphingosine-1-phosphocholine in which the ceramide N-acyl group is specified as hexadecanoyl (palmitoyl).


A phosphocholine carrying an O-(4-diazoniophenyl) substituent.


lysophosphatidylcholine 26:0

A lysophosphatidylcholine in which the remaining acyl group (position not specified) contains 26 carbons and 0 double bonds.


A sphingomyelin in which the sphingoid component is specified as icosaphytosphingosine.


phosphatidylcholine 35:3

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 35 carbons in total with 3 double bonds.


A phosphatidylcholine 38:1 in which the acyl groups at positions 1 and 2 are specified as (9Z)-octadecenoyl and eicosanoyl respectively.


A phosphatidylcholine 38:5 in which the acyl groups at positions 1 and 2 are hexadecanoyl and (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl respectively.


A primary ammonium ion that is the conjugate acid of thiamine(1+) resulting from the protonation of the primary amino group.


A lysophosphatidylcholine 17:0 in which the acyl group at position 1 is 1-heptadecanoyl and the hydroxy group at position 2 is unsubstituted.


A phosphatidylcholine O-30:2 in which the alkyl and acyl group specified at positions 1 and 2 are (9Z)-hexadecenyl and (9Z)-tetradecenoyl respectively.


A phosphatidylcholine O-36:0 in which the alkyl and acyl groups specified at positions 1 and 2 are octadecyl and octadecanoyl respectively.


A N-hexadecenoylsphingosine-1-phosphocholine in which the amino group of sphingosine is in amide linkage with a 9Z-hexadecenoyl fatty acid.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the 1-acyl group is specified as palmitoyl.


Any lysoglycerophosphocholine having an oxidized fatty acyl chain at sn-2. Major species at pH 7.3.


A phosphatidylcholine 38:4 in which one acyl group has 16 carbons and is fully saturated while the other has 22 carbons and 4 double bonds (position not specified).


phosphatidylcholine 34:6

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 34 carbons in total with 6 double bonds.


A phosphatidylcholine 38:6 in which the acyl groups specified at positions 1 and 2 are (9Z,12Z)-octadecadienoyl and (5Z,8Z,11Z,14Z)-icosatetraenoyl respectively.


A phosphatidylcholine 34:3 in which the acyl groups specified at positions 1 and 2 are palmitoyl and (6Z,9Z,12Z)-octadecatrienoyl (gamma-linolenoyl) respectively.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups specified at positions 1 and 2 are palmitoyl and (11Z)-eicosenoyl respectively.


phosphatidylcholine O-32:2

An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 32 carbons and 2 double bonds.


A sphingomyelin 33:2 obtained by formal condensation of the carboxy group of pentadecanoic acid with the amino group of any sphingadienine-1-phosphocholine.


lysophosphatidylcholine (16:1/0:0)

A lysophosphatidylcholine 16:1 in which the acyl group is located at position 1.


A phosphatidylcholine 38:6 in which the acyl groups specified at positions 1 and 2 are (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl and hexadecanoyl respectively.


An N-acyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine in which the acyl group has 25 carbons and 0 double bonds.


A sphingomyelin d18:1 in which the acyl group specified is tetradecenoyl.


A sphingomyelin in which the total number of carbons in the fatty acyl group is 24 with 1 double bond.


A sphingomyelin 40:2 obtained by formal condensation of the carboxy group of docosanoic acid with the amino group of any sphingadienine-1-phosphocholine.


sphingomyelin d18:1/24:1

A sphingomyelin d18:1 in which the fatty acyl group contains 24 carbons and 1 double bond.


A phosphatidylcholine 36:0 where the acyl substituents at positions 1 and 2 are icosanoyl and palmitoyl respectively.


sphingomyelin d18:1

Any sphingomyelin having sphingosine as the sphingoid component.


lysophosphatidylcholine 20:3

A lysophosphatidylcholine in which the acyl group contains 20 carbons with 3 double bonds. If R1 is an acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is an acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.


A phosphatidylcholine 40:6 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (9Z,11Z,13Z,15Z,17Z,19E)-docosahexaenoyl respectively.


A  phosphatidylcholine 36:4 in which the acyl groups specified at positions 1 and 2 are (6Z,9Z,12Z)-octadecatrienoyl and (9Z)-octadecenoyl respectively.


A sphingomyelin d18:1 in which the acyl group specified is heneicosanoyl.


A phosphatidylcholine 36:2 in which the phosphatidyl acyl groups at positions 1 and 2 are both oleoyl.


phosphatidylcholine P-40:6

A 1-O-(alk-1-enyl)-2-O-acyl-sn-glycero-3-phosphocholine in which the alk-1-enyl and acyl groups contain a total of 40 carbon atoms with 6 additional double bonds.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at positions 1 and 2 are specified as (9Z)-hexadecenoyl and acetyl respectively.


A phosphatidylcholine 36:3 in which the acyl groups at positions 1 and 2 are specified as octadecadienoyl and octadecenoyl respectively.


A N-hexacosenoylsphingosine-1-phosphocholine consisting of sphingosine as the sphingoid base acylated at the N atom by a (17Z)-hexacosenoyl group.


phosphatidylcholine 32:3

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 32 carbons in total with 3 double bonds.


sn-monothiophosphatidylcholine

A monothioglycerophosphocholine that is an sn-1- or -2-monothioglycero-3-phosphocholine bearing one or two acyl substituents at positions 1 and/or 2.


sphingomyelin d18:1/18:0

A sphingomyelin d18:1 in which the fatty acyl group contains 18 carbons and is fully saturated.


A  1-(Z)-alk-1-enyl-2-acyl-sn-glycero-3-phosphocholine in which the alk-1-enyl and acyl groups are specified as (1Z)-octadecenyl and linoleoyl (9Z,12Z-octadecadienoyl) respectively.


A phosphatidylcholine 36:6 in which the acyl groups at positions 1 and 2 tetradecanoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


phosphatidylcholine O-40:4

An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 40 carbons and 4 double bonds.


sphingomyelin 24:1

A sphingomyelin in which the total number of carbons contained in the sphingoid base and fatty acyl groups is 24 with 1 double bond.


phosphatidylcholine 28:6

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 28 carbons in total with 6 double bonds.


A 2-acyl-sn-glycero-3-phosphocholine obtained by formal condensation of one of the carboxy groups of azelaic acid with the 1-hydroxy group of sn-glycero-3-phosphocholine.


A phosphatidylcholine 38:4 in which the two acyl substituents at positions 1 and 2 are specified as stearoyl and arachidonoyl respectively.


A phosphatidylcholine 27:0 in which the acyl groups at positions 1 and 2 are specified as octadecanoyl and nonanoyl respectively.


A glycerophosphocholine that is glycero-3-phosphocholine carrying unspecified alk-1-enyl and acyl groups at positions 1 and 2 respectively. Major species at pH 7.3.


A 2-alkyl-sn-glycero-3-phosphocholine in which the alkyl group is specified as hexadecyl.


phosphatidylcholine 32:6

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 32 carbons in total with 6 double bonds.


phosphatidylcholine 13:0

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl groups contain a total of 13 carbons and no double bonds.


A  phosphatidylcholine 34:2 in which the acyl groups specified at positions 1 and 2 are (9Z,12Z)-octadecadienoyl and linoleoyl respectively.


A phosphatidylcholine O-36:1 in which the alkyl and acyl groups specified at positions 1 and 2 are hexadecyl and (9Z)-eicosenoyl respectively.


A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as pentadecanoyl.


A lysophosphatidylcholine 18:2 in which the acyl group at position 1 is (9Z,12Z)-octadecadienoyl.


A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as icosanoyl.


A lysophosphatidylcholine 20:1 in which the acyl group is located at position 1.


phosphatidylcholine 42:6

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 42 carbons in total with 6 double bonds.


An N-acyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine in which the acyl group has 21 carbons and 0 double bonds and is 2-hydroxylated.


An N-acylsphinganine-1-phosphocholine in which the ceramide N-acyl group is specified as nonadecanoyl.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the 1- and 2-acyl groups are specified as hexadecanoyl and 9-oxononanoyl respectively.


lysophosphatidylcholine 19:1

A lysophosphatidylcholine in which the remaining acyl group (position unspecified) contains 19 carbons and 1 double bond.


A phosphatidylcholine 36:5 in which the acyl groups specified at positions 1 and 2 are hexadecanoyl and (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl respectively.


A phosphosphingolipid that is 15-methylhexadecasphing-4-enine substituted at position 1 by a phosphocholine moiety


sphingomyelin 38:1

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 38 with 1 double bond.


A 1-oleoyl-2-acyl-sn-glycero-3-phosphocholine in which the acyl substituent at position 2 is specified as acetyl.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 21 carbons and 4 double bonds and is 2-hydroxylated.


phosphatidylcholine 44:5

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 44 carbons in total with 5 double bonds.


A sphingomyelin 42:2 obtained by formal condensation of the carboxy group of tetracosanoic acid with the amino group of any sphingadienine-1-phosphocholine.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 22 carbons and 1 double bond.


phosphatidylcholine O-40:0

An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 40 carbons and 0 double bonds.


A phosphatidylcholine O-34:2 in which the alkyl and acyl groups specified at positions 1 and 2 are hexadecyl and [(9Z,12Z)-octadecadienoyl respectively.


A phosphatidylcholine 32:2 in which the acyl groups specified at positions 1 and 2 are tetradecanoyl and (9Z,12Z)-octadecadienoyl respectively.


phosphatidylcholine 35:4

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 35 carbons in total with 4 double bonds.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 26 carbons and 2 double bonds.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at positions 1 and 2 are specified as hexadecanoyl and (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoyl respectively.


A sphingomyelin obtained by formal condensation of the carboxy group of tetracosanoic acid with the amino group of 14-methylhexadecasphinganine-1-phosphocholine. It is a metabolite of the nematode Caenorhabditis elegans.


A phosphatidylcholine 36:5 in which the acyl groups specified at positions 1 and 2 are (9Z)-hexadecenoyl and (5Z,8Z,11Z,14Z)-eicosatetraenoyl respectively.


sphingomyelin 44:0

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 44 with 0 double bonds.


A sphingomyelin 43:2 obtained by formal condensation of the carboxy group of any tetracosenoic acid with the amino group of nonadecasphingosine-1-phosphocholine.


A 1,2-diacyl-sn-glycero-3-phosphocholine where the acyl groups at positions 1 and 2 are palmitoyl and icosanoyl respectively.


A 2-acyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl and the acyl groups at positions 1 and 2 are specified as hexadecyl and 4-hydroxybutyl respectively.


phosphatidylcholine P-34:3

A 1-O-(alk-1-enyl)-2-O-acyl-sn-glycero-3-phosphocholine in which the alk-1-enyl and acyl groups contain a total of 34 carbon atoms with 3 additional double bonds.


A 1-(Z)-alk-1-enyl-sn-glycero-3-phosphocholine in which the alkenyl group is (1Z,9Z)-octadecadienyl.


phosphatidylcholine 26:2

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 26 carbons in total with 2 double bonds.


sphingomyelin 22:0

A sphingomyelin in which the total number of carbons contained in the sphingoid base and fatty acyl groups is 22 with zero double bonds.


flutropium

A carboxylic ester resulting from the formal condensation of the carboxy group of hydroxy(diphenyl)acetic acid with the hydroxy group of (3-endo,8-syn)-8-(2-fluoroethyl)-3-hydroxy-8-methyl-8-azoniabicyclo[3.2.1]octane. Its bromide salt is used as a drug for the treatment asthma and chronic obstructive pulmonary disease.


phosphatidylcholine 35:2

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 35 carbons in total with 2 double bonds.


sphingomyelin 43:7

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 43 with 7 double bonds.


A phosphatidylcholine 24:0 in which the acyl groups specified at positions 1 and 2 are undecanoyl and tridecanoyl respectively.


1-acyl-2-palmitoyl-sn-glycero-3-phosphocholine in which the 1-acyl group is specified as heptanoyl.


A phosphatidylcholine 34:0 in which the two acyl substituents at positions 1 and 2 are specified as stearoyl and palmitoyl respectively.


phosphatidylcholine 44:0

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 44 carbons in total with 0 double bonds.


sphingomyelin 44:1

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 44 with 1 double bond.


A sphingomyelin 39:1 obtained by formal condensation of the carboxy group of docosanoic acid with the amino group of 15-methylhexadecasphingosine-1-phosphocholine. It is a metabolite of the nematode Caenorhabditis elegans.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl substituents at positions 1 and 2 are specified as stearoyl and acetyl respectively.


lysophosphatidylcholine O-17:0

A monoalkyl-sn-glycero-3-phosphocholine in which the alkyl group (position not specified) contains 17 carbons and is fully saturated.


lysophosphatidylcholine 14:1(9Z)/0:0

A lysophosphatidylcholine 14:1 in which the remaining acyl group is (9Z)-tetradecenoyl.


A 1,2-diacyl-sn-glycero 3-phosphocholine in which the acyl group at position 1 is unspecified while that at position 2 is specified as (S)-12-hydroxyoleoyl.


(R)-bethanechol

The (R)-enantiomer of bethanechol.


A lysophosphatidylcholine 18:1 in which the acyl group specified as position 1 is (11Z)-octadecenoyl.


A sphingomyelin in which the sphingoid component is specified as tetradecasphinganine.


A phosphatidylcholine 36:0 in which the acyl groups at positions 1 and 2 are tetradecanoyl and docosanoyl respectively.


A phosphatidylcholine O-40:6 in which the alkyl and the acyl groups at positions 1 and 2 are octadecyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


acylcholine

A choline ester formed from choline and a carboxylic acid.


A phosphatidylcholine 28:0 in which the two acyl substituents at positions 1 and 2 are specified as lauroyl and palmitoyl respectively.


A sphingomyelind18:1 in which   the total number of carbons in the fatty acyl group is 26 with 2 double bonds.


An N-hydroxytetracosenoylsphingosine-1-phosphocholine in which the N-acyl group is specified as (15Z)-3-hydroxytetracos-15-enoyl.


A 2-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as octanoyl.


name: 3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide


A 1-O-acyl-sn-glycero-3-phosphocholine obtained by hydroxylation at position 8 of 1-O-oleoyl-sn-glycero-3-phosphocholine.


A phosphatidylcholine 42:0 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and tetracosanoyl respectively.


An N-acyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine in which the acyl group has 28 carbons and 0 double bonds and is 2-hydroxylated.


A phosphatidylcholine 26:0 in which the two acyl substituents at positions 1 and 2 are palmitoyl and decanoyl respectively.


A sphingomyelin 44:0  in which the N-acyl group and sphingoid base are specified as hexacosanoyl and sphinganine respectively.


phosphatidylcholine 33:2

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 33 carbons in total with 2 double bonds.


phosphatidylcholine O-38:2

A glycerophosphocholine that is an alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 38 carbons and 2 double bonds.


phosphatidylcholine 44:1-OH

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 44 carbons in total with 1 double bond and 1 hydroxy group.


A sphingomyelin d18:1 in which the ceramide N-acyl group is specified as (11Z)-icosenoyl.


phosphatidylcholine 37:3

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 37 carbons in total with 3 double bonds.


phosphatidylcholine 36:5

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 36 carbons in total with 5 double bonds.


A phosphatidylcholine O-38:2 in which the alkyl and acyl groups specified at positions 1 and 2 are octadecyl and (11Z,14Z)-eicosadienoyl respectively.


An sn-glycero-3-phosphocholine compound having a palmitoyl substituent at the 1-hydroxy position


lysophosphatidylcholine 24:0

A lysophosphatidylcholine in which the remaining acyl group (position not specified) contains 24 carbons and 0 double bonds.


A 1-palmitoyl-2-acyl-sn-glycero-3-phosphocholine in which the 2-acyl group has 20 carbons and 3 double bonds.


A phosphatidylcholine 37:5 in which the acyl groups at positions 1 and 2 are specified as heptadecenoyl and icosatetraenoyl respectively.


A lysophosphatidylcholine 22:4 in which the acyl group is specified as (7Z,10Z,13Z,16Z)-docosatetraenoyl and is located at position 1.


An sn-monothiophosphatidylcholine in which the acyl substituents at O-1 and S-2 are hexadecyl and hetanoyl respectively; an analogue of diheptanoyl thio-PC that contains an ether-linked saturated C16 moiety at the sn-1 position rather than a heptanoyl thiol ester.


sphingomyelin d18:1/23:3

A sphingomyelin d18:1 in which the total number of carbons in the fatty acyl group is 23 with 3 double bonds.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at positions 1 and 2 are pentadecanoyl and (5Z,8Z,11Z,14Z)-eicosatetraenoyl respectively.


A lysophosphatidylcholine 18:1 in which the acyl group is at position 1 is elaidoyl [(9E)-octadec-9-enoyl] and the hydoxy group at position 2 is unsubstituted.


A sphingomyelin 39:1 obtained by formal condensation of the carboxy group of docosanoic acid with the amino group of heptadecasphingosine-1-phosphocholine.


A phosphatidylcholine 36:4 in which the acyl groups at positions 1 and 2 are octadecanoyl and (6Z,9Z,12Z,15Z)-octadecatetraenoyl respectively.


A sphingomyelin d18:1 in whihc the acyl group specified is nonadecanoyl.


A glycerophosphocholine that is glycero-3-phosphocholine carrying one alkyl and one acyl group in unspecified positions. Major species at pH 7.3.


A galactose phosphate consisting of N-acetyl-D-galactosamine having a choline phosphate group at the 6-position.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 24 carbons and 0 double bonds and is 2-hydroxylated.


phosphatidylcholine 24:0

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 24 carbons in total with 0 double bonds.


sphingomyelin 42:1

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 42 with 1 double bond.


A  phosphatidylcholine 30:0 in which the acyl group specified at positions 1 and 2 is pentadecanoyl.


An N-acyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine in which the acyl group has 17 carbons and 0 double bonds and is 2-hydroxylated.


phosphatidylcholine 15:1

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl groups contain a total of 15 carbons and 1 double bond.


An N-acylsphinganine-1-phosphocholine obtained by formal condensation of the carboxy group of any octadecenoic acid with the amino group of sphinganine-1-phosphocholine.


A phosphatidylcholine 36:2 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (2E,4E)-octadecadienoyl respectively.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 24 carbons and 4 double bonds and is 2-hydroxylated.


A N-acylsphinganine-1-phosphocholine in which the acyl group specified is tricosanoyl.


lysophosphatidylcholine 24:1

A lysophosphatidylcholine in which the remaining acyl group (position not specified) contains 24 carbons and 1 double bond.


lysophosphatidylcholine 20:3/0:0

A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group at C-1 contains 20 carbons and 3 double bonds.


phosphatidylcholine 42:11

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl groups contain a total of 42 carbons and 11 double bonds.


phosphatidylcholine 44:2-OH

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 44 carbons in total with 2 double bonds and 1 hydroxy group.


A sphingomyelin obtained by formal condensation of the carboxy group of docosanoic acid with the amino group of 14-methylhexadecasphinganine-1-phosphocholine. It is a metabolite of the nematode Caenorhabditis elegans.


A phosphatidylcholine 36:2 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (10Z,12Z)-octadecadienoyl respectively


lysophosphatidylcholine P-18:1/0:0

A lysophosphatidylcholine P-18:1 in which the alkenyl group is located at position 1.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 28 carbons and 0 double bonds.


A sphingomyelin 34:0 in which the N-acyl group and sphingoid base are specified as hexadecanoyl and phytosphingosine respectively.


lysophosphatidylcholine (0:0/18:1)

A lysophosphatidylcholine 18:1 in which the acyl group is located at position 2.


lysophosphatidylcholine 17:1

A lysophosphatidylcholine in which the remaining acyl group contains 17 carbons and 1 double bond. If R1 is acyl and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is acyl then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.


lysophosphatidylcholine 16:2

A lysophosphatidylcholine in which the remaining acyl group contains 16 carbons and 2 double bonds. If R1 is the acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is the acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.


phosphatidylcholine O-40:2

An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 40 carbons and 2 double bonds.


lysophosphatidylcholine P-18:3

A 1-O-(alk-1-enyl)-sn-glycero-3-phosphocholine in which the alk-1-enyl group contains 18 carbons and 3 additional double bonds.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 18 carbons and 0 double bonds and is 2-hydroxylated.


phosphatidylcholine O-44:0

A glycerophosphocholine that is an alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 44 carbons and 0 double bonds.


A phosphatidylcholine 38:0 in which the acyl groups specified at positions 1 and 2 are tetradecanoyl and tetracosanoyl respectively.


phosphatidylcholine 26:0

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 26 carbons in total with 0 double bonds.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 20 carbons and 1 double bond.


An N-acyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine in which the acyl group has 26 carbons and 0 double bonds and is 2-hydroxylated.


sphingomyelin 28:0

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 28 with 0 double bonds.


A phosphatidylcholine O-38:0 in which the alkyl and acyl groups specified at positions 1 and 2 are hexadecyl and docosanoyl respectively.


sphingomyelin 44:2

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 44 with 2 double bonds.


sphingomyelin 30:4

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 30 with 4 double bonds.


A phosphatidylcholine 36:4 in which one acyl group has 16 carbons and is fully saturated while the other has 20 carbons and 4 double bonds (position not specified).


A phosphatidylcholine 26:0 in which the acyl groups at positions 1 and 2 are specified as octadecanoyl and octanoyl respectively.


sphingomyelin 40:1

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 40 with 1 double bond.


phosphatidylcholine 44:10

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 44 carbons in total with 10 double bonds.


phosphatidylcholine 36:8

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl groups contain a total of 36 carbons and 8 double bonds.


A lysophosphatidylcholine 18:0 in which the acyl group is specified as stearoyl (octadecanoyl) and is located at position 2.


A phosphatidylcholine 34:1 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 11Z-octadecenoyl (cis-vaccenoyl) respectively.


A sphingomyelin 41:1 in which the N-acyl group and sphingoid base are specified as tricosanoyl and sphingosine respectively.


A phosphatidylcholine 40:5 in which the acyl groups at C-1 and C-2 are octadecanoyl and (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl substituents at positions 1 and 2 are specified as palmitoyl and acetyl respectively.


phosphatidylcholine 40:8

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 40 carbons in total with 8 double bonds.


A phosphatidylcholine (22:4/20:4) which carries a (6Z,9Z,12Z,15Z)-22-oxodocosa-6,9,12,15-tetraen-22-yl group at position 1 and a (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl group at position 2.


sphingomyelin 44:5

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 44 with 5 double bonds.


An alkylacylglycero-3-phosphocholine in which the alkyl and acyl groups are located at positions 1 and 2 respectively. Major species at pH 7.3.


p-aminophenylphosphocholine

A phosphocholine that is the 4-aminophenyl ester of choline phosphate.


A phosphatidylcholine 30:2 in which the acyl groups specified at positions 1 and 2 are (9Z)-hexadecenoyl and (9Z)-tetradecenoyl respectively.


phosphatidylcholine 38:3

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 38 carbons with 3 double bonds.


A lysophosphatidylcholine 18:2 in which the acyl group is specified as linoleoyl and is located at position 2.


A 1-(alk-1-enyl)-2-oleoyl-sn-glycero-3-phosphocholine in which the alk-1-enyl group has Z geochemistry.


A phosphatidylcholine 24:0 in which the acyl groups specified at positions 1 and 2 are nonanoyl and pentadecanoyl respectively.


phosphatidylcholine O-28:0

An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 28 carbons and no double bonds.


A  1-O-acyl-sn-glycero-3-phosphocholine in which the 1-acyl group is (9Z)-hexadecenoyl (palmitoleoyl).


A lysophosphatidylcholine 18:0 in which the acyl substituent is located at position 1 and is specified as stearoyl.


sphingosylphosphocholine acid

A cationic phosphosphingolipid consisting of sphingosine having a phosphocholine moiety attached to its primary hydroxyl group.


A phosphatidylcholine 37:4 in which the acyl substituents at positions 1 and 2 are specified as heptadecanoyl and arachidonoyl respectively.


phosphatidylcholine O-38:4

A glycerophosphocholine that is an alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 38 carbons and 4 double bonds.


A 2-acyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl and the acyl groups at positions 1 and 2 are specified as hexadecyl and succinyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at positions 1 and 2 are specified as heptadecanoyl and (9Z,12Z,15Z)-octadecatrienoyl respectively.


A sphingomyelin d18:1 in which the ceramide N-acyl group contains 24 carbons, 1 hydroxy group and 1 double bond.


phosphatidylcholine 10:0

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl groups contain a total of 10 carbons and no double bonds.


DIMYRISTOYLPHOSPHATIDYLCHOLINE

A 1,2-diacyl-sn-glycero-3-phosphocholine where the two phosphatidyl acyl groups are specified as tetradecanoyl (myristoyl).


A N-acylsphinganine-1-phosphocholine in which the acyl group specified is (15Z)-tetracosenoyl.


sphingomyelin 35:1

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 35 with 1 double bond.


phosphatidylcholine P-32:1

A 1-O-(alk-1-enyl)-2-O-acyl-sn-glycero-3-phosphocholine in which the alk-1-enyl and acyl groups contain a total of 32 carbon atoms with 1 additional double bond.


A phosphatidylcholine 38:0 in which the acyl groups at positions 1 and 2 are specified as eicosanoyl and octadecanoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the phosphatidyl acyl groups at positions 1 and 2 are both arachidonoyl.


sphingomyelin 36:3

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 36 with 3 double bonds.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 17 carbons and 0 double bonds.


sphingomyelin d18:1/26:1

A sphingomyelin d18:1 in which the fatty acyl group contains 26 carbons and 1 double bond.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 19 carbons and 1 double bond.


phosphatidylcholine 35:0

A phosphatidylcholine in which the two acyl groups contain a total of 35 carbons and no double bonds.


A phosphatidylcholine 34:1 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z-octadecenoyl (oleoyl) respectively.


A 1-acyl-2-alkyl-sn-glycero-3-phosphocholine in which the acyl and alkyl groups at positions 1 and 2 are specified respectively as arachidonoyl and palmityl.


phosphatidylcholine 12:0

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl groups contain a total of 12 carbons and no double bonds.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 16 carbons and 0 double bonds and is 2-hydroxylated.


phosphatidylcholine 44:1

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 44 carbons in total with 1 double bond.


phosphatidylcholine O-42:1

An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 42 carbons and 1 double bond.


sphingomyelin 38:3

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 38 with 3 double bonds.


(R)-EDELFOSINE

A 1-octadecyl-2-methylglycero-3-phosphocholine that is the (R)-enantiomer of edelfosine.


A sphingomyelin 42:1 obtained by formal condensation of the carboxy group of pentacosanoic acid with the amino group of 14-methylhexadecasphingosine-1-phosphocholine. It is a metabolite of the nematode Caenorhabditis elegans.


azelaoyl-PAF

A 2-acyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl and the acyl groups at positions 1 and 2 are specified as hexadecyl and 8-carboxyoctanoyl respectively.


A phosphatidylcholine 28:0 in which the two acyl substituents at positions 1 and 2 are specified as palmitoyl and lauroyl respectively.


phosphatidylcholine 40:4

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 40 carbons in total and 4 double bonds.


cholines

A quaternary ammonium ion based on the choline ion and its substituted derivatives thereof.


phosphatidylcholine O-35:2

An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 35 carbons and 2 double bonds.


A phosphatidylcholine O-36:5 in which the alkyl and acyl groups specified at positions 1 and 2 are hexadecyl and (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl respectively.


sphingomyelin 32:0

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 32 with 0 double bonds.


lysophosphatidylcholine O-18:2

A monoalkylglycerophosphocholine in which the alkyl group contains 18 carbons and 2 double bonds. If R1 is an alkenyl group and R2 is a hydrogen then the molecule is a 1-alkenyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is an alkenyl group then the molecule is a 2-alkenyl-sn-glycero-3-phosphocholine.


An N-hydroxydocosenoylsphingosine-1-phosphocholine in which the N-acyl group is specified as (13Z)-3-hydroxydocos-13-enoyl.


Any 1-acyl-sn-glycero-3-phosphocholine that has an oxidized fatty acyl component. Major species at pH 7.3.


A phosphatidylcholine O-36:0 in which the alkyl and acyl groups specified at positions 1 and 2 are hexadecyl and eicosanoyl respectively.


phosphatidylcholine 39:4

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 39 carbons in total with 4 double bonds.


The ammonium betaine of a 1-O-acyl-sn-glycero-3-phosphocholine arising from deprotonation of the phosphate OH; major species at pH 7.3.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which 1 and 2-acyl groups are specified as palmitoyl (hexadecanoyl) and (10E)-9-hydroperoxyoctadecenoyl respectively.


A phosphatidylcholine 34:0 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and octadecanoyl (stearoyl) respectively.


A phosphatidylcholine O-42:2 in which the alkyl and acyl groups specified at positions 1 and 2 are icosyl and (13Z,16Z)-docosadienoyl respectively.


A phosphatidylcholine O-32:1 in which the alkyl and acyl groups specified at positions 1 and 2 are tetradecyl and (9Z)-octadecenoyl respectively.


phosphatidylcholine O-34:1

A glycerophosphocholine that is an alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 34 carbons and 1 double bond.


A sphingomyelin d18:1 in which the N-acyl group is specified as docosanoyl


phosphatidylcholine O-36:1

A glycerophosphocholine that is an alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 36 carbons and 1 double bond.


phosphatidylcholine P-40:5

A 1-O-(alk-1-enyl)-2-O-acyl-sn-glycero-3-phosphocholine in which the alk-1-enyl and acyl groups at positions 1 and 2 contain 40 carbon atoms in total with 5 additional double bonds.


A 1-(Z)-alk-1-enyl-sn-glycero-3-phosphocholine in which the alk-1-enyl group is specified as (1Z)-octadecenyl.


phosphatidylcholine O-40:3

An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 40 carbons and 3 double bonds.


lysophosphatidylcholine (22:4/0:0)

A lysophosphatidylcholine 22:4 in which the docosatetraenoyl group is located at position 1.


A 1-octadecanoyl-2-octadecenoyl-sn-glycero-3-phosphocholine in which the acyl groups specified at positions 1 and 2 are (11Z)-octadecenoyl and octadecanoyl respectively.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 25 carbons and 2 double bonds.


lysophosphatidylcholine 19:2

A lysophosphatidylcholine in which the remaining acyl group (position unspecified) contains 19 carbons and 2 double bonds.


A sphingomyelin  d18:1 in which the ceramide N-acyl group contains 14 carbons, 1 hydroxy group and 1 double bond.


lysophosphatidylcholine 14:1

A lysophosphatidylcholine in which the remaining acyl group contains 14 carbons and 1 double bond. If R1 is the acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is the acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.


A phosphatidylcholine 34:1 in which one acyl group has 16 carbons and is fully saturated while the other has 18 carbons and 1 double bond (position not specified).


A sphingomyelin in which the sphingoid component is specified as hexadecaphytosphingosine.


phosphatidylcholine O-30:2

An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 30 carbons and 2 double bonds.


phosphatidylcholine 37:4

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 37 carbons in total with 4 double bonds.


sphingomyelin

Any of a class of phospholipids in which the amino group of a sphingoid base is in amide linkage with one of several fatty acids, while the terminal hydroxy group of the sphingoid base is esterified to phosphorylcholine.


A sphingomyelin 39:1 obtained by formal condensation of the carboxy group of docosanoic acid with the amino group of 14-methylhexadecasphingosine-1-phosphocholine. It is a metabolite of the nematode Caenorhabditis elegans.


1-palmitoyl-2-acyl-sn-glycero-3-phosphocholine in which the 2-acyl group is specified as heptanoyl.


phosphatidylcholine 40:6

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl groups contain forty carbons in total with six double bonds.


A lysophosphatidylcholine 22:5 in which the acyl group at position 1 is (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl and the hydroxy group at position 2 is unsubstituted.


A sphingomyelin 34:0 in which the N-acyl group and sphingoid base are specified as hexadecanoyl and sphinganine respectively.


A phosphatidylcholine 24:0 in which the acyl groups specified at positions 1 and 2 are tridecanoyl and undecanoyl respectively.


quaternary ammonium ion

A derivative of ammonium, NH4(+), in which all four of the hydrogens bonded to nitrogen have been replaced with univalent (usually organyl) groups.


Stage IIIB Cervical Cancer FIGO 2018

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: Cervical carcinoma with extension to the pelvic wall and/or hydronephrosis or nonfunctioning kidney (unless known to be due to another cause). (FIGO 2018)


Leaflet Disruption Due To Calcification

description: The disturbance of a cusp of a heart valve secondary to the accumulation of calcium on the valve tissue. This most often results in stenosis of the valve.


Leaflet Disruption

description: The disturbance of a cusp of a heart valve, often resutling in dysfunction of the valve.


Leaflet Disruption Due To Infection

description: The disturbance of a cusp of a heart valve secondary to infection affecting the valve tissue, which can result in valvular dysfunction.


Leaflet Disruption Due To Unknown Cause

description: The disturbance of a cusp of a heart valve without an identifiable cause.


name: Leaflet Disruption Due To Host Tissue Overgrowth

description: The disturbance of a cusp of a heart valve secondary to an increase in tissue mass at the valve site, which can lead to valve dysfunction. This often happens as a result of fibrosis of tissue surrounding the suture line of a prosthetic valve.


name: Leaflet Disruption Due To Suture Abrasion

description: The disturbance of a cusp of a heart valve secondary to irritation by surgical sutures, which can result in valvular dysfunction.


Vulvar Fibroadenoma

description: A benign epithelial-stromal neoplasm that arises from the vulva and resembles the breast fibroadenoma.


name: Fibroadenoma of Anogenital Mammary-Type Glands

description: A benign epithelial-stromal neoplasm that arises from the perineum and resembles the breast fibroadenoma.


Anal Fibroadenoma

description: A benign epithelial-stromal neoplasm that arises from the anus and resembles the breast fibroadenoma.


name: Esophageal Squamous Intraepithelial Neoplasia

description: A lesion in which the architectural and cytologic abnormalities involve either the lower or both the lower and the upper half of the esophageal squamous epithelium.


name: High Grade Esophageal Squamous Intraepithelial Neoplasia

description: A lesion in which the architectural and cytologic abnormalities involve both the lower and the upper half of the esophageal squamous epithelium.


name: Low Grade Esophageal Squamous Intraepithelial Neoplasia

description: A lesion in which the architectural and cytologic abnormalities are confined to the lower half of the esophageal squamous epithelium.


name: Extramedullary Disease in Multiple Myeloma Involving the Liver

description: Infiltration of the hepatic sinusoids by malignant (clonal) plasma cells in patients with history of multiple myeloma.


ganglioside GM2 (24:1)

A sialotriaosylceramide that is N-acetyl-beta-D-galactosaminyl-(1->4)-alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-N-acylsphingosine in which the acyl group on the sphingosine nitrogen is tetracos-15-enoyl. A constituent of natural ganglioside GM2.


A 5-HETrE consisting of (6E,8Z,11Z)-icosatrienoic acid in which the 5-hydroxy group has S-configuration.


GALLOCATECHIN

A gallocatechin  that has (2R,3S)-configuration. It is found in green tea and bananas.


name: Unresectable Diffuse Midline Glioma, H3 K27M-Mutant

description: Diffuse midline glioma, H3 K27M-mutant that is not amenable to surgical resection.


Unresectable Diffuse Midline Glioma

description: Diffuse midline glioma that is not amenable to surgical resection.


CTPB

A benzamide obtained by formal condensation of the carboxy group of 2-ethoxy-6-pentadecylbenzoic acid with one of the amino groups of 4-chloro-3-(trifluoromethyl)aniline.


A secondary amino compound that is ammonia in which nitrogen is substituted by a 1-(4-methoxy-3-sulfamoylphenyl)propan-2-yl group and a 2-(2-ethoxyphenoxy)ethyl group.


name: Stage IIIA Gastric Gastrointestinal Stromal Tumor

description: Stage IIIA includes: T3, N0, M0, Mitotic rate: High. T3: Tumor more than 5 cm, but not more than 10 cm, in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)


cis-golgicide A

A racemate comprising equimolar amounts of (3aR,4S,9bS)- and (3aS,4R,9bR)-golgicide A. Commercially available golgicide A is a 10:1 mixture of cis- and trans-golgicide A; the (3aS,4R,9bR) stereoisomer is the most active.


name: Stage IIIA Rectal Neuroendocrine Tumor AJCC v8

description: Stage IIIA includes: T4, N0, M0. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Colorectal Neuroendocrine Tumor by AJCC v8 Stage

description: A term that refers to the staging of a colorectal neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This staging system applies to colorectal "carcinoid" tumors (neuroendocrine tumor G1 and G2, and rare-well differentiated G3). High-grade neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas of the colon and rectum are not staged using this staging system. (from AJCC 8th Ed.)


name: Stage I Colorectal Neuroendocrine Tumor AJCC v8

description: Stage I includes: T1, N0, M0. T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage IIB Colon Neuroendocrine Tumor AJCC v8

description: Stage IIB includes: T3, N0, M0. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage IIB Rectal Neuroendocrine Tumor AJCC v8


name: Stage IIIB Colon Neuroendocrine Tumor AJCC v8

description: Stage IIIB includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0); (T4, N1, M0). T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage IIIB Rectal Neuroendocrine Tumor AJCC v8


name: Rectal Neuroendocrine Tumor by AJCC v8 Stage

description: A term that refers to the staging of a rectal neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This staging system applies to rectal "carcinoid" tumors (neuroendocrine tumor G1 and G2, and rare-well differentiated G3). High-grade neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas of the rectum are not staged using this staging system. (from AJCC 8th Ed.)


name: Stage IIB Colorectal Neuroendocrine Tumor AJCC v8


name: Stage IIA Colorectal Neuroendocrine Tumor AJCC v8

description: Stage IIA includes: T2, N0, M0. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage IIA Rectal Neuroendocrine Tumor AJCC v8


name: Colon Neuroendocrine Tumor by AJCC v8 Stage

description: A term that refers to the staging of a colon neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This staging system applies to colon "carcinoid" tumors (neuroendocrine tumor G1 and G2, and rare-well differentiated G3). High-grade neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas of the colon are not staged using this staging system. (from AJCC 8th Ed.)


name: Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8


name: Stage I Colon Neuroendocrine Tumor AJCC v8


name: Stage IIIA Colon Neuroendocrine Tumor AJCC v8


name: Stage IIA Colon Neuroendocrine Tumor AJCC v8


name: Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8


A steroidal acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 12alpha-hydroxy-3-oxochola-4,6-dien-24-oic acid.


An alpha-D-galactoside that is the 2-aminoethyl glycoside of a tetrasaccharide consisting of beta-D-glucuronosyl, beta-D-glucosyl, alpha-D-glucosyl and alpha-D-galactosyl residues linked sequentially (1->4).


6-bromo-2-naphthyl alpha-D-galactoside

An alpha-D-galactoside having a 6-bromo-2-naphthyl substituent at the anomeric position.


fagopyritol B1

An alpha-D-galactoside that is 1D-chiro-inositol having an alpha-D-galactosyl residue attached at position 2 via a glycosidic linkage.


An alpha-D-glucoside that is the 2-aminoethyl glycoside of a tetrasaccharide consisting of two beta-D-glucosyl residues, an alpha-D-glucosyl residue and (at the reducing end) an alpha-D-galactosyl residue, all linked sequentially (1->4).


An alpha-D-glucoside that is the 2-aminoethyl glycoside of a pentasaccharide consisting of  alpha-D-galactosyl, beta-D-glucuronosyl, beta-D-glucosyl, alpha-D-glucosyl and alpha-D-galactosyl residues, all linked sequentially (1->4).


An amino disaccharide that is 2-acetamido-2-deoxy-beta-D-glucopyranose in which the hydroxy group at position 3 has been converted into the corresponding alpha-D-galactopyranoside.


A glycosyl glycoside consisting of two alpha-D-galactopyranose residues joined by a (1->1) glycosidic bond.


A glycosyl glycoside that is alpha-D-galactopyranose in which the anomeric hydroxy group has been converted into the corresponding alpha-D-glucopyranosyl derivative.


A fatty amide resulting from the formal condensation of the carboxy group of cerotic acid with the amino group of (2S,3S,4R)-2-aminononane-1,3,4-triol and in which the primary hydroxy group of the resulting product has been converted to the corresponding alpha-D-galactopyranoside.


A disaccharide that is D-glucopyranose in which the hydroxy group at position 2 has been converted into the corresponding alpha-D-galactopyranoside.


An alpha-D-galactoside having a 4-methylumbelliferyl substituent at the anomeric position


An alpha-D-glucoside that is the 2-aminoethyl glycoside of a hexasaccharide consisting of alpha-D-glucosyl, alpha-D-galactosyl, beta-D-glucuronosyl, beta-D-glucosyl, alpha-D-glucosyl and alpha-D-galactosyl residues, all linked sequentially (1->4).


A disaccharide that is L-fucopyranose in which the hydroxy group at position 4 has been converted into the corresponding alpha-D-galactopyranoside.


adxanthromycin A

An organic peroxide, which is the 3-alpha-D-galactopyranosyl substituted derivative of the dimer obtained by oxidation at the 10-hydroxy position of (10S)-3,8,10-trihydroxy-1,7,10-trimethyl-9-oxo-9,10-dihydroanthracene-2-carboxylic acid. It is isolated from the fermentation broth of Streptomyces.


An amino pentasaccharide consisting of alpha-L-fucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose, beta-D-galactopyranose, and 2-acetamido-2-deoxy-beta-D-glucopyranose joined in sequence by (1->4), (1->3), and (1->4) glycosidic bonds and in which the hydroxy group at position 3 of the non-terminal 2-acetamido-2-deoxy-beta-D-glucopyranose moiety has been to the corresponding alpha-D-galactopyranoside.


4-nitrophenyl alpha-D-galactoside

An alpha-D-galactopyranoside having a 4-nitrophenyl substituent at the anomeric position.


An alpha-D-Galp-(1->4)-D-Glcp in which the carbon bearing the anomeric hydroxy group has beta configuration.


A carboxylic ester obtained by formal condensation of 9-(alpha-D-galactosyloxy)nonanoic acid and methanol.


A alpha-D-Galp-(1->4)-D-Glcp in which the carbon bearing the anomeric hydroxy group has alpha configuration.


isofloridoside

A galactosylglycerol that is glycerol in which one of the primary hydroxy groups has been converted into the corresponding alpha-D-galactopyranoside.


A isofloridoside in which position 2 of the glyceryl moiety has R configuration.


A glycosylglucose that is D-glucopyranose in which the hydroxy group at position 4 has been converted into the corresponding alpha-D-galactoside.


A cyclitol ether that is D-myo-inositol carrying methyl and alpha-D-galactosyl substituents at positions 4 and 3 respectively.


A disaccharide that is D-mannitol in which the hydroxy group at position 2 has been converted into its alpha-D-galactopyranoside


An alpha-D-glucoside that is the 2-aminoethyl glycoside of a trisaccharide consisting of  beta-D-glucosyl, alpha-D-glucosyl and alpha-D-galactosyl residues linked sequentially (1->4).


An alpha-D-Galp-(1->2)-D-Glcp in which the carbon bearing the anomeric hydroxy group has alpha configuration.


An amino disaccharide that is 2-acetamido-beta-D-glucopyranose in which the hydroxy group at position 6 has been glycosylated by an alpha-D-galactopyranosyl group.


An alpha-D-galactoside having a 1D-myo-inositol substituent at the anomeric position.


fagopyritol A1

An alpha-D-galactoside having a 1D-chiro-inositol substituent at the anomeric position.


A secondary fatty alcohol that is tetradecane substituted by a hydroxy group at position 6.


Pregnancy with Intrauterine Device

category: biolink:PhenotypicFeature biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: Co-existence of an intrauterine pregnancy with an intrauterine device.


A dTDP-sugar having 3,4-didehydro-2,6-dideoxy-alpha-D-glucose as the sugar component.


triarylmethane

Any benzenoid aromatic compound containing three aryl groups connected by a single C atom.


name: Head and Neck Phosphaturic Mesenchymal Tumor

description: A phosphaturic mesenchymal tumor that arises from the head and neck. It usually affects the paranasal sinuses. The head and neck region is the most frequently involved site for phosphaturic mesenchymal tumors, following the appendicular skeleton.


name: Appendicular Skeleton Phosphaturic Mesenchymal Tumor

description: A phosphaturic mesenchymal tumor that arises from the appendicular skeleton. The appendicular skeleton is the most frequently involved site for phosphaturic mesenchymal tumors.


name: Malignant phosphaturic mesenchymal tumor

description: A phosphaturic mesenchymal tumor characterized by the presence of nuclear atypia, high mitotic activity, increased cellularity, marked pleomorphism, and necrosis. It usually develops in lesions that have recurred locally and metastasizes to other sites.


CLOMAZONE

An isoxazolidinone that is 1,2-oxazolidin-3-one substituted by a 2-chlorobenzyl group at position 2 and two methyl groups at position 4.


A FAHFA obtained by formal condensation of the carboxy group of palmitic acid with the hydroxy group of 11-hydroxystearic acid.


D-glycero-D-manno-heptose 7-phosphate

D-glycero-D-manno-heptose in which the hydrogen of the primary hydroxy group is substituted by a dihydrogen phosphate group.


The 1-alpha-anomer of D-glycero-D-manno-heptose 7-phosphate.


D-glycero-beta-D-manno-heptose in which the hydrogens of the hydroxy groups at positions 1 and 7 are substituted by dihydrogen phosphate groups.


Dianion of D-glycero-D-manno-heptose 1-phosphate arising from deprotonation of both phosphate OH groups.


D-glycero-D-manno-heptose 1-phosphate(2-) with alpha-configuration at the anomeric carbon atom.


D-glycero-D-manno-heptose 1-phosphate(2-) with beta-configuration at the anomeric carbon atom.


D-glycero-alpha-D-manno-heptose in which the hydrogens of the hydroxy groups at positions 1 and 7 are substituted by dihydrogen phosphate groups.


The 1-beta-anomer of D-glycero-D-manno-heptose 7-phosphate.


D-glycero-D-manno-heptose in which the hydrogens of the hydroxy groups at positions 1 and 7 are substituted by dihydrogen phosphate groups.


name: Metastatic malignant neoplasm to trachea

description: A malignant neoplasm that has spread to the trachea from another anatomic site.


An alpha-D-glucoside that is the 5-aminopentyl glycoside of a branched heptasaccharide consisting of alpha-D-glucuronosyl, beta-D-mannosyl, alpha-D-glucosyl, beta-D-glucosyl, beta-D-mannosyl and beta-D-glucosyl residues linked sequentially (1->3), (1->4), (1->3), (1->4) and (1->4), to the mannosyl residue proximal to the reducing end of which has also linked (1->3) to it an alpha-D-glucuronosyl residue. The 5-aminopentyl group at the reducing end is a spacer to enable further conjugation to a carrier protein for immunological studies.


icosa-5,8,12,14-tetraenoic acid

Any icosatetraenoic acid with the double bonds at positions 5, 8, 12 and 14.


icosatetraenoic acid

A 20-carbon, polyunsaturated fatty acid having four double bonds at unspecified positions.


icosa-5,8,11,13-tetraenoic acid

Any icosatetraenoic acid with the double bonds at positions 5, 8, 11 and 13.


all-cis-8,11,14,17-icosatetraenoic acid

An icosatetraenoic acid having four cis double bonds at positions 8, 11, 14 and 17.


(5Z,8Z,10E,12E)-icosatetraenoic acid

An icosatetraenoic acid in which the four double bonds are located at positions 5, 8, 10 and 12 (the 5Z,8Z,10E,12E-isomer).


icosa-5,8,10,14-tetraenoic acid

Any icosatetraenoic acid with the double bonds at positions 5, 8, 10 and 14.


icosa-6,8,10,14-tetraenoic acid

Any icosatetraenoic acid with the double bonds at positions 6, 8, 10 and 14.


icosa-5,7,11,14-tetraenoic acid

Any icosatetraenoic acid with the double bonds at positions 5, 7, 11 and 14.


icosa-7,9,11,14-tetraenoic acid

Any icosatetraenoic acid with the double bonds at positions 7, 9, 11 and 14.


icosa-5,9,11,14-tetraenoic acid

Any icosatetraenoic acid with the double bonds at positions 5, 9, 11 and 14.


(5Z,11Z,14Z,17Z)-icosatetraenoic acid

An icosatetraenoic acid in which the four double bonds have Z configuration and are located at positions 5, 11, 14 and 17.


icosa-6,8,11,14-tetraenoic acid

Any icosatetraenoic acid with the double bonds at positions 6, 8, 11 and 14.


icosa-5,8,11,14-tetraenoic acid

Any icosatetraenoic acid with the double bonds at positions 5, 8, 11 and 14.


(R)-tetraconazole

A 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole that is the (R)-enantiomer of tetraconazole.


TETRACONAZOLE

A racemate comprising equal amounts of (R)- and (S)-tetraconazole.  A fungicide used to control a range of fungal infections including powdery mildew, rusts, bunt, loose smut and scab.


(S)-tetraconazole

A 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole that is the (S)-enantiomer of tetraconazole.


name: Bilateral Synchronous Sporadic Renal Cell Carcinoma

description: Non-hereditary renal cell carcinoma arising from a kidney and detected in the other kidney within six months of the first primary. The majority are clear cell renal cell carcinomas.


Kidney Germ Cell Tumor

description: A rare benign or malignant germ cell tumor that arises from the kidney.


MAGNESIUM CHLORIDE

A hydrate that is the hexahydrate form of magnesium dichloride.


paraben

A 4-hydroxybenzoate ester in which the esterifying alcohol is an alkanol (in diagram, R = alkyl). Commonly used as preservatives in cosmetic and pharmaceutical products.


Arteriovenous graft thrombosis

description: Partial or complete occlusion of the lumen of an arteriovenous graft by a thrombus.


A steroidal acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 3-oxochenodeoxycholic acid.


name: Refractory Childhood Acute Lymphoblastic Leukemia

description: Acute lymphoblastic leukemia that occurs in childhood and does not respond to treatment.


Childhood Acute Basophilic Leukemia

description: An acute basophilic leukemia occurring in children.


A 1-phosphatidyl-1D-myo-inositol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as (8Z,11Z,14Z,17Z)-icosatetraenoyl and octadecanoyl respectively.


Sinonasal Solitary Fibrous Tumor

description: A solitary fibrous tumor that arises from the nasal cavity and paranasal sinuses.


A tetrachlorobiphenyl that is biphenyl in which the hydrogens at position 3 and 4 on each phenyl group are replaced by chlorines.


Supernumerary Hemivertebra

description: More than the usual or expected number of hemivertebra.


A member of the class of phenylureas that is urea in which one of the nitrogens bears a 3-tert-butyl-1-[(3S)-3-carboxy-1,2,3,4-tetrahydroisoquinolin-6-yl]-1H-pyrazol-5-yl substituent, while the other bears a 2,3-dichlorophenyl group.


A 3beta-hydroxy steroid that is cathasterone which is lacking the oxo substituent at position 6.


name: Malignant neoplasm of hypopharynx recurrent

description: The reemergence of a hypopharyngeal malignant neoplasm after a period of remission.


Benign neoplasm of pyriform sinus

description: A neoplasm that arises from the pyriform sinus and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.


Neoplasm of pyriform sinus

description: A benign or malignant neoplasm that affects the pyriform sinus.


COVID-19-Associated Anosmia

description: Anosmia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).


A steroid acid that is 5beta-cholestan-26-oic acid which is substituted by hydroxy groups as the 3alpha, 7alpha, and 12alpha positions.


Tentorial tear due to birth trauma

description: Pertaining to tears involving the tentorium of the cerebellum.


ETHION

An organic thiophosphate that is S,S'-methanediyl bis[dihydrogen (phosphorodithioate)] in which all the hydroxy groups have been converted to their corresponding ethyl esters respectively. Ethion is an organophosphate insecticide with inhibitory activity towards the enzyme acetylcholinesterase ( EC 3.1.1.7).


An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (2E,11Z,14Z,17Z)-icosatetraenoic acid.


LEHUALIDE F

A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by a methoxy group at position 3, a hydroxy group at position 4, a methyl group at position 5 and a (2E)-3-methyl-9-phenylnon-2-en-1-yl group at position 6. Isolated from the marine sponge of the genus Plakortis, it exhibits cytotoxicity against human promyeloid leukemic HL-60 cells.


Resectable Carcinoma

description: Carcinoma that is amenable to surgical resection.


name: Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

description: Cutaneous squamous cell carcinoma of the head and neck that is amenable to surgical resection.


Resectable Periampullary Adenocarcinoma

description: Periampullary adenocarcinoma that is amenable to surgical removal.


name: Resectable Liver and Intrahepatic Bile Duct Carcinoma

description: Liver carcinoma that is amenable to surgical resection.


Resectable Merkel Cell Carcinoma

description: Merkel cell carcinoma that is amenable to surgical resection.


Resectable Digestive System Carcinoma

description: Digestive system carcinoma that is amenable to surgical resection.


Resectable Skin Squamous Cell Carcinoma

description: Skin squamous cell carcinoma that is amenable to surgical resection.


name: Localized Resectable Adult Liver Carcinoma

description: A localized hepatocellular carcinoma or intrahepatic cholangiocarcinoma that occurs during adulthood and it is amenable to surgical resection.


name: Resectable Head and Neck Squamous Cell Carcinoma

description: Squamous cell carcinoma of the head and neck which is amendable to surgical removal.


name: Resectable Ampulla of Vater Adenocarcinoma

description: Ampulla of Vater adenocarcinoma that is amenable to surgical resection.


Resectable Appendix Carcinoma

description: Appendix carcinoma that is amenable to surgical resection.


Resectable Gastric Adenocarcinoma

description: Gastric adenocarcinoma that is amenable to surgical resection.


Resectable Endometrial Carcinoma

description: Endometrial carcinoma that is amenable to surgical resection.


Resectable Skin Carcinoma

description: Skin carcinoma that is amenable to surgical resection.


Small intestine carcinoma resectable

description: Carcinoma of the small intestine amendable to resection.


Resectable Colon Carcinoma

description: Colon carcinoma that is amenable to surgical resection.


Resectable Esophageal Carcinoma

description: Esophageal carcinoma that is amenable to surgical resection.


Resectable Gallbladder Adenocarcinoma

description: Gallbladder adenocarcinoma that is amenable to surgical resection.


name: Localized Resectable Adult Hepatocellular Carcinoma

description: A localized hepatocellular carcinoma that occurs during adulthood and it is amenable to surgical resection.


name: Resectable Gastroesophageal Junction Adenocarcinoma

description: Gastroesophageal junction adenocarcinoma that is amenable to surgical resection.


Resectable Cervical Carcinoma

description: Cervical carcinoma that is amenable to surgical resection.


Carcinoma duodenum resectable

description: Carcinoma of the duodenum amendable to surgical removal.


Resectable Colorectal Carcinoma

description: Colorectal carcinoma that is amenable to surgical resection.


Carcinoma liver resectable

description: A hepatocellular carcinoma that is amenable to surgical resection.


Resectable Esophageal Adenocarcinoma

description: Esophageal adenocarcinoma that is amenable to surgical resection.


Resectable Bladder Urothelial Carcinoma

description: Bladder urothelial carcinoma that is amenable to surgical resection.


asenapine maleate

A racemate consisting of equal amounts of (R,R)- and (S,S)-asenapine maleate. Used for the acute treatment of schizophrenia and acute treatment of manic or mixed episodes associated with bipolar I disorder with or without psychotic features.


A secondary fatty alcohol that is henicosane substituted by a hydroxy group at position 2.


name: 5-[4-[methyl-[(3-methyl-2-thiophenyl)methyl]amino]-6-quinazolinyl]-2-furancarboxylic acid ethyl ester


A dihydroceramide in which the ceramide N-acyl group is specified as (15Z)-tetracosenoyl (nervonoyl).


name: Childhood Cerebellar Anaplastic Astrocytoma

description: A cerebellar anaplastic astrocytoma that occurs during childhood.


sulcofuron-sodium

The sodium salt of sulcofuron.


A 2-pyranone in which the hydrogens at positions 4 and 6 of 2H-pyran-2-one are replaced by hydroxy and 2-oxotridecyl groups respectively.


pApA

A 5'-phospho-(3'->5')-dinucleotide composed from two AMP residues.


A 4-hydroxy-D-proline in which the hydroxy group at position 4 has S-configuration.


Stage II Lip Cancer AJCC v6 and v7

description: Stage II includes: T2, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)


Lower Gingival Verrucous Carcinoma

description: A verrucous carcinoma of the oral cavity that arises from the lower gingiva.


name: Verrucous carcinoma of the oral cavity recurrent

description: Reemergence of verrucous carcinoma of the oral cavity after a period of remission.


Tongue Verrucous Carcinoma

description: A well differentiated squamous cell carcinoma arising from the tongue.  It is an exophytic, warty, slow growing tumor, usually affecting older males. It is associated with the chronic use of smokeless tobacco.


Buccal Mucosa Verrucous Carcinoma

description: A verrucous carcinoma of the oral cavity that arises from the buccal mucosa.


Oral Cavity Carcinoma Cuniculatum

description: A variant of well-differentiated squamous cell carcinoma arising from the oral cavity. It is characterized by the presence of minimal cytological atypia, multiple keratin-filled crypts, and intraepithelial neutrophils.


Upper Gingival Verrucous Carcinoma

description: A verrucous carcinoma of the oral cavity that arises from the upper gingiva.


The S-(trans-4-carboxybut-2-enoyl) derivative of coenzyme A.


Positive Laboratory Test Result

description: A laboratory test result that indicates that a specific disease, condition, or attribute being assessed is present.


Expression Positive

description: An indication that the expression of a gene, transcript or protein has been detected in a sample.


An androstanoid that is testosterone substituted at C2  by a hydroxy group with undefined stereochemistry.


An androstanoid that is testosterone carrying an additional hydroxy substituent at the 2beta-position.


laminarabiose

A glycosylglucose consisting of D-glucose with undefined anomeric stereochemistry and a beta-D-glucosyl residue attached at the 3-position.


A laminarabiose having beta-configuration at the reducing end anomeric centre.


A glycotriaosylceramide having N-propionyl-beta-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl as the triaosyl component.


A glycotetraosylceramide having beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucose as the tetrasaccharide component.


A glycotetraosylceramide having a beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc component attached to the primary hydroxy function of a ceramide with undefined sphingoid base and fatty acyl chain.


A 1,2-diacyl-3-alpha-D-galactosyl-sn-glycerol in which the groups at the 1- and 2-positions are both oleoyl.


A carboxyalkyl phosphate consisting of D-glyceric acid having an alpha-D-glucosyl residue at the 2-position and a phospho group at the 3-position


D-glucosyl-N-hexanoylsphingosine

A D-glucosyl-N-acylsphingosine in which the ceramide N-acyl group is specified as hexanoyl.


hydramacrophyllol A

An isobenzofuranone that is 2-benzofuran-1(3H)-one substituted by a hydroxy group at position 7 and a (S)-hydroxy(4-hydroxyphenyl)methyl group at position 3. It has been isolated from the roots of Scorzonera judaica.


3-O-beta-D-glucosyl-D-glucuronic acid

A disaccharide consisting beta-D-glucosyl and D-glucuronic acid residues joined by a (1->3)-linkage.


Refractory Hairy Cell Leukemia Variant

description: Hairy cell leukemia variant that is resistant to treatment.


name: HHV-8-Associated Multicentric Castleman Disease

description: Multicentric Castleman disease associated with HHV8 infection.


Sellar Chondroid Chordoma

description: A chondroid chordoma that arises from the sellar region.


Conventional Chordoma

description: A malignant bone tumor arising from the remnants of the fetal notochord. It is characterized by the presence of large epithelioid cells with clear to light eosinophilic cytoplasm. Some of the cells are large with bubbly, vacuolated cytoplasm (physaliphorous cells). The cells form cords and nests that are embedded within an extracellular myxoid matrix.


A glycophytoceramide having an alpha-D-galactopyranosyl residue at the O-1 position and a 15-phenylpentadecanoyl group attached to the nitrogen.


An N-acyl-L-alanine resulting from the formal condensation of the amino group of L-alanine with the carboxy group of (15S)-hydroperoxy-(5Z,8Z,11Z,13E)-icosatetraenoic acid.


dicamba-methyl

The methyl ester of dicamba.


remdesivir triphosphate

An organic triphosphate that is GS-441524 in which the 5'-hydroxy group has been replaced by a triphosphate group. It is the active metabolite of remdesivir.


description: An adenocarcinoma that arises from the sinonasal tract. It is characterized by the absence of features that resemble intestinal adenocarcinoma.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the phosphatidyl acyl groups at postions 1 and 2 are specified as heptadecanoyl and lauroyl respectively.


Recurrent Malignant Mastocytosis

description: The reemergence of malignant mastocytosis after a period of remission.


Recurrent Mast Cell Leukemia

description: The reemergence of mast cell leukemia after a period of remission.


name: Psychogenic Musculoskeletal Chest Pain with Dysfunctional Breathing

description: A condition in which there is musculoskeletal chest pain associated with inappropriate hyperpnea or tachypnea. (ACC/AHA)


Psychogenic Musculoskeletal Chest Pain

description: A condition in which there is the sensation of musculoskeletal chest pain due to a conversion disorder. (ACC/AHA)


Sellar Gangliocytoma

description: A tumor that arises in the sellar region and is characterized by the presence of mature ganglion cells and neuronal differentiation. It is often associated with the presence of pituitary neuroendocrine tumors/adenomas.


Double-Negative Prostate Carcinoma

description: A metastatic, castration-resistant prostate carcinoma that is composed of fibroblast growth factor-driven malignant cells.


name: Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents

description: Castration-resistant prostate carcinoma which is refractory to second-generation androgen receptor axis-targeted agents, namely abiraterone and enzalutamide.


name: Intermediate Atypical Prostate Carcinoma

description: An aggressive, castration-resistant, histologically distinct, metastatic carcinoma arising from the prostate gland. It is characterized by the presence of a pure population of cytologically bland malignant epithelial cells with moderate to abundant cytoplasm and rare mitotic figures. The prognosis is poor.


Aggressive Variant Prostate Carcinoma

description: A lethal form of advanced castration-resistant prostate carcinoma that emerges in the later stages of castration-resistant treatment. It is an adaptive response to androgen receptor pathway inhibition. The morphologic features vary, ranging from poorly differentiated carcinomas to mixed adenocarcinoma-small cell carcinomas to pure small cell carcinomas expressing neuroendocrine markers. Clinically, it manifests with rapidly progressive disease, visceral or lytic bone metastases and bulky tumor masses. Molecular studies have shown the loss of tumor suppressor genes TP53 and RB1.


A synthetic beta-D-glucoside that is a branched pentadecasaccharide derivative consisting of three beta-D-Glc-(1->6)-[alpha-L-Rha-(1->3)]-alpha-D-Glc-(1->3)-alpha-L-Rha2Ac-(1->3)-beta-D-GlcNAc pentasaccharide units linked (1->4) between the GlcNac residue at the reducing end of one unit and the OH at position 4 of the alpha-D-glucose residue of the adjacent unit. An aminoethyl linker from the reducing-end GlcNAc residue allows for efficient conjugation to a carrier protein.


A glycohexaosylceramide having alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc as the glycohexaosyl component.


Advanced Unfavorable Hodgkin Lymphoma

description: An advanced Hodgkin lymphoma with unfavorable prognosis.


tubocapsanolide F

A  withanolide that is 5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione substituted by hydroxy groups at positions 4 and 17 (the 4beta,5beta,6beta,22R stereoisomer). Isolated from Tubocapsicum anomalum, it exhibits cytotoxic activity.


allylamine antifungal drug

An organonitrogen compound that contains an amino group that is attached to a carbon which is itself attached to an olefinic carbon and which has been used as an antifungal drug.


Situs inversus thoracis

description: A congenital condition in which there is complete right-to-left reversal of the position of the thoracic organs.


ethyl-dUTP

An organic triphosphate formed by condensation between the gamma-phospho group of 2'-deoxyuridine 5'-triphosphate and ethanol.


thiocyclam hydrochloride

A hydrochloride salt resulting from the formal reaction of equimolar amounts of thiocyclam and hydrogen chloride. A nicotinic acetylcholine receptor agonist used as a broad-spectrum insecticide. Not approved for use within the European Union.


Urethritis Glandularis

description: A reactive inflammatory disorder affecting the urethra.  It is characterized by the development of small cysts in the urethral wall.  The cysts are lined by metaplastic glandular cells.


magnesium oxide nanocrystal

A nanocrystal composed of magnesium oxide.


Dialysis Catheter Tunnel Infection

description: Local infection involving the subcutaneously tunneled portion of a dialysis catheter.


A 1-(Z-alk-1-enyl)-sn-glycero-3-phosphoglycerol in which the non-alkylated glycerol moiety has R-configuration.


A member of the class of glycerophosphoglycerols that is sn-glycero-3-phosphoglycerol carrying an unspecified Z-alk-1-enyl substituent at position 1


name: Oncocytic Variant of Chromophobe Renal Cell Carcinoma

description: A rare variant of chromophobe renal cell carcinoma that exhibits oncocytoma-like features.


name: Lugano Classification Stage IV Adult Hodgkin Lymphoma AJCC v8

description: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or noncontiguous extralymphatic organ involvement in conjunction with nodal stage II disease; or any extralymphatic organ involvement in nodal stage III disease. Stage IV includes any involvement of the CSF, bone marrow, liver, or lungs (other than by direct extension in stage IIE disease). (from AJCC 8th Ed.)


name: Lugano Classification Stage IV Adult Lymphoma AJCC v8


An inositol phosphomannosylinositol phosphoceramide compound having a tetracosanoyl group attached to the ceramide nitrogen, hydroxylation at C-4 of the long-chain base, and hydroxylation at C-2 and C-3 of the very-long-chain fatty acid.


ESOXYBUTYNIN

A 4-(diethylamino)but-2-yn-1-ol yhat has S configuration. In contrast to the (R)- enantiomer, esoxybutynin exhibits essentially no anticholinergic activity.


A 17-oxo steroid that is 5alpha-androstan-17-one substituted by a beta-hydroxy group at positions 3 and an alpha-hydroxy group at position 7.


name: Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8

description: Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)


(2E,11R)-11-hydroxydodec-2-enoic acid

An (omega-1)-hydroxy fatty acid that is trans-2-dodecenoic acid in which the 11-pro-R hydrogen is replaced by a hydroxy group.


Astrocytoma, Not Otherwise Specified

description: A central nervous system tumor with morphological features of astrocytoma in which there is insufficient information on the IDH genes status.


name: Ciliary Body Benign Teratoid Medulloepithelioma

description: A rare, unilateral, benign embryonal neoplasm typically presenting as a ciliary body mass during childhood. It arises from primitive medullary epithelium and contains heterologous elements, particularly cartilage, skeletal muscle, and brain tissue.


Recurrent Extragonadal Seminoma

description: The reemergence of extragonadal seminoma after a period of remission.


name: Recurrent Malignant Extragonadal Germ Cell Tumor

description: The reemergence of malignant extragonadal germ cell tumor after a period of remission.


name: Recurrent Malignant Extragonadal Nongerminomatous Germ Cell Tumor

description: The reemergence of a malignant extragonadal nongerminomatous germ cell tumor after a period of remission.


Stage IA Cervical Cancer FIGO 2018

description: Invasive cervical carcinoma that can be diagnosed only by microscopy, with maximum depth of invasion less than 5 mm. (FIGO 2018)


Stage IA2 Cervical Cancer FIGO 2018

description: Cervical carcinoma with measured stromal invasion equal or more than 3 mm and less than 5 mm in depth. (FIGO 2018)


Stage IA1 Cervical Cancer FIGO 2018

description: Cervical carcinoma with measured stromal invasion less than 3 mm in depth. (FIGO 2018)


The D-enantiomer of 4-hydroxyleucine.


A leucine derivative that is leucine substituted by a hydroxy group at position 4.


The L-enantiomer of 4-hydroxyleucine.


name: 2-amino-1-[2-(4-morpholinyl)ethyl]-3-pyrrolo[3,2-b]quinoxalinecarboxylic acid ethyl ester


rhosin

A D-tryptophan derivative obtained by formal condensation of the carboxy group of D-tryptophan with the amino group of (quinoxalin-6-yl)methylidenehydrazide. It directly targets the Rho GEF binding domain, thereby preventing Rho from interacting with its GEFs


name: 2-cyano-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetic acid cyclohexyl ester


quinoxaline pesticide

A quinoxaline derivative that has pesticidal properties.


QUIZALOFOP ETHYL ESTER

An ethyl ester resulting from the formal condensation of the carboxy group of 2-{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoic acid with ethanol.


PROPAQUIZAFOP

A quinoxaline derivative used as systemic herbicide for annual and perennial grasses.


2-methylquinoxaline-6-carboxylic acid

A quinoxaline derivative in which the quinoxaline (1,4-naphthyridine) skeleton is substituted with a carboxy function at C-6 and a methyl group at C-2.


name: 1-[3-[1-cyano-2-oxo-2-[(phenylmethyl)amino]ethyl]-2-quinoxalinyl]-3-piperidinecarboxylic acid ethyl ester


PI 3-Kg inhibitor

A quinoxaline derivative  that is quinoxaline in which the hydrogen at position 6 is replaced by a (2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl group. It is a potent inhibitor of the PI3Kgamma, with an IC50 of 8 nM and inhibits the progression of joint inflammation and damage in both lymphocyte-independent and dependent mouse models of rheumatoid arthritis.